A
AGMB
AgomAb Therapeutics NV American Depositary Shares
$8.69
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of AgomAb Therapeutics NV American Depositary Shares in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Key figures
Dividend per share
—
Yield
—
EPS
-$1.28
P/E
—
Data as of Oct 8
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.
Posts
No posts about AGMB yet.
About AgomAb Therapeutics NV American Depositary Shares
AgomAb Therapeutics is a Belgian biotech company whose shares trade in the US. It develops experimental drugs for diseases that cause scarring and stiffening of organs, such as lung and liver fibrosis. It has no products on the market and no sales. Any future income depends on its drugs passing clinical trials and winning approval from regulators.